Drug Safety

Is Aspirin a Cause of Reye's Syndrome?: A Case Against
pp. 225-231(7)
Authors: Orlowski J.P.; Hanhan U.A.; Fiallos M.R.

Topical Nonsteroidal Anti-Inflammatory Drugs for Ophthalmic Use: A Safety Review
pp. 233-250(18)
Authors: Gaynes B.I.; Fiscella R.

A Systematic Review of the Safety of Kava Extract in the Treatment of Anxiety
pp. 251-261(11)
Authors: Stevinson C.; Huntley A.; Ernst E.

Safety of Non-Antiarrhythmic Drugs that Prolong the QT Interval or Induce Torsade de Pointes: An Overview
pp. 263-286(24)
Authors: Ponti F.D.; Poluzzi E.; Cavalli A.; Recanatini M.; Montanaro N.

Determinants of Headache in Lansoprazole Users in The Netherlands: Results from a Nested Case-Control Study
pp. 287-295(9)
Authors: Claessens A.A.M.C.; Heerdink E.R.; van Eijk J.T.H.M.; Lamers C.B.H.W.; Leufkens H.G.M.

Should Celecoxib be Contraindicated in Patients Who Are Allergic to Sulfonamides?
pp. 297-300(4)
Author: Wiholm B-E.

Should Celecoxib be Contraindicated in Patients Who Are Allergic to Sulfonamides?: The Authors Reply
pp. 297-300(4)
Authors: Shear N.H.; Knowles S.; Shapiro L.